You are currently viewing a new version of our website. To view the old version click .

Advances in Influenza Virus Vaccines

This special issue belongs to the section “Influenza Virus Vaccines“.

Special Issue Information

Dear Colleagues,

The current pandemic has greatly accelerated advances in vaccine research and production. The question that emerges at this point, however, is: Will these advances in vaccinology benefit other infectious diseases, other than COVID-19?

In recent years, we have witnessed improvements in existing influenza vaccine technologies aiming to overcome problems such as possible egg adaptation and immunosenescence, triggered mainly by lower effectiveness of influenza vaccines against the A/H3N2 influenza virus.

This Special Issue of Vaccines on “Advances in Influenza Virus Vaccines” aims to bring together the work of scientists that aim to further improve influenza vaccine technology in order to bring about greater vaccine effectiveness. Research as well as opinion papers are welcome.

Dr. George Kassianos
Prof. Dr. Raul Ortiz De Lejarazu
Dr. Ivan Aloysius
Dr. Iván Sanz Muñoz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X